IPGP Q1 Deep Dive: Battery and Medical Demand Drive Revenue Growth Amid Margin Pressures

Fiber laser manufacturer IPG Photonics (NASDAQ:IPGP) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 16.6% year on year to $265.5 million. The company expects next quarter’s revenue to be around $275 million, close to analysts’ estimates. Its non-GAAP profit of $0.29 per share was 6.9% below analysts’ consensus estimates.

Is now the time to buy IPGP? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

IPG Photonics faced a challenging first quarter, as the market reacted negatively to the results despite strong year-over-year revenue growth. Management credited the solid top-line performance to demand for laser solutions in battery manufacturing and medical applications, with CEO Mark Gitin noting, “We continue to see improved demand for our laser solutions, particularly in battery manufacturing and medical applications, which drove our strong performance in the quarter.” However, operating margin pressures and inventory build-up were notable concerns, with management acknowledging ongoing challenges from tariffs and higher input costs.

Looking ahead, IPG Photonics’ guidance reflects both optimism around continued industrial and medical demand and caution due to margin headwinds. Management highlighted growth initiatives in Advanced Solutions, including medical, semiconductor, and defense applications, as key contributors to future performance. CFO Tim Mammen cautioned that gross margins will continue to face pressure from tariffs and underabsorbed costs, stating, “We expect the impact from tariffs to persist in 2026 and continue to work on ways to offset their impact, including cost reduction and pricing initiatives.”

Key Insights from Management’s Remarks

Management attributed Q1 growth to strong performance in Industrial Solutions, especially welding and cutting for battery manufacturing, and progress in medical and semiconductor sectors, while also noting margin pressures from tariffs and litigation costs.

• Industrial Solutions momentum: The company saw robust year-over-year growth in Industrial Solutions, with welding and cutting applications benefiting from increased demand in battery manufacturing for both electric vehicles and stationary storage.
• Medical and semiconductor progress: Advanced Solutions had mixed results, but medical and semiconductor segments posted gains, with medical revenue boosted by new customer wins and semiconductor growth tied to AI-driven demand for GPUs and high-bandwidth memory chips.
• Regional sales trends: North America and Asia, particularly China and Japan, experienced notable revenue growth, while Europe remained stable. The strength in China was driven by battery and additive manufacturing applications.
• Systems business strategy: IPG is moving up the value chain by integrating fiber lasers into complete systems, enabling solutions for complex industrial problems and deepening customer partnerships, particularly in cleaning and welding.
• Margin and cost headwinds: Despite revenue growth, operating margin declined due to ongoing tariff-related costs, underabsorbed manufacturing expenses, and a one-time litigation settlement with TRUMPF Laser System, prompting continued focus on operational efficiencies and pricing strategies.

Drivers of Future Performance

IPG Photonics’ outlook is shaped by ongoing demand in its core industrial and medical markets, but tempered by persistent cost and margin pressures.

• Tariff and cost management: Management expects tariffs to remain a significant headwind, impacting gross margins by about 150 basis points, and continues to prioritize cost reduction and pricing initiatives to mitigate these effects.
• Product innovation pipeline: The company is investing in new product approvals and launches in medical and defense, such as the Crossbow laser defense system and medical device extensions, aiming to expand its addressable market and support multi-year growth.
• Operational efficiency initiatives: Efforts to streamline operations and balance fixed manufacturing costs are ongoing, with the goal of improving absorption rates and supporting long-term margin expansion, though management acknowledged these results will take time to materialize.

Catalysts in Upcoming Quarters

In the coming quarters, our analysts will monitor (1) the pace of adoption for new medical and defense laser products, (2) the ability of cost and pricing initiatives to offset ongoing tariff-related margin pressure, and (3) sustained growth in battery and semiconductor applications, particularly in China and North America. Progress on operational efficiencies will also be a key indicator of margin recovery.

IPG Photonics currently trades at $91.24, down from $122.33 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).

Our Favorite Stocks Right Now

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.